An agreement with Shimadzu was announced during a press conference at the ASMS on June 6th.
We also had the pleasure of welcoming several scientist at our booth and introduce them to the Luxon ion source.
Follow the links bellow to have access to the posters we presented at ASMS 2017
MP 711 Monday : Combined Screening and Quantitative Confirmation of 110 Drugs in Urine by LDTD-MS/MS Using a Generic SPE Procedure
TP 232 Tuesday : Generic Extraction Method for Screening of 8 Drugs of Abuse in Saliva with a Quick Turnaround Analysis by LDTD-MS/MS;Driver under influence_Drug Testing_ASMS 2017_final
WP101 Wednesday: Dipyridamole High Throughput Analysis of Drug Metabolism Cells Assay using LDTD-MS/MSDipyridamole cell buffer_plasmas_ASMS 2017_final
WP 105 Wednesday: Label Free High Throughput Screening of Amino Acid Based Assays: Old Tricks, New Speed using LDTD-MS/MSPierrePicard_ASMS 2017_final
ThP 140 Thursday: Hematocrit Effect: Any Influence in Plasmas Sample Analysis or just a DBS Concern?Hematocrite effect_plasmas_ASMS 2017_final
ThP 141 Thursday: In Tips Micro-Sampling Comparison with Standard Volume Plasma Protein Precipitation with an On-Line Sample Preparation SystemOn-line RTC extraction_ASMS2017_final
It was a pleasure to meet all of you, thank you for passing by to see us!